Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4): a Multicentre, Randomised, Controlled, Phase III Study

NCT02730338 is registered in ClinicalTrials.gov with Movember Foundation as lead sponsor.

NCT NCT02730338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02730338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4): a Multicentre, Randomised, Controlled, Phase III Study
Lead sponsor
Movember Foundation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 31, 2016
Completion date
October 31, 2026
Enrollment
866 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer